Zobrazeno 1 - 10
of 28 968
pro vyhledávání: ''
Autor:
Leena Chehab, David R. Doody, Adam J. Esbenshade, Gregory M.T. Guilcher, Christopher C. Dvorak, Brian T. Fisher, Beth A. Mueller, Eric J. Chow, Jenna Rossoff
Publikováno v:
Journal of Clinical Oncology. 41:364-372
PURPOSE Infections pose a significant risk during therapy for childhood cancer. However, little is known about the risk of infection in long-term survivors of childhood cancer. METHODS We performed a retrospective observational study of children and
Autor:
Fornecker, Luc-Matthieu, Lazarovici, Julien, Aurer, Igor, Casasnovas, René-Olivier, Gac, Anne-Claire, Bonnet, Christophe, Bouabdallah, Krimo, Feugier, Pierre, Specht, Lena, Molina, Lysiane, Touati, Mohamed, Borel, Cécile, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Pascal, Laurent, Lugtenburg, Pieternella, Di Renzo, Nicola, Vander Borght, Thierry, Traverse-Glehen, Alexandra, Dartigues, Peggy, Hutchings, Martin, Versari, Annibale, Meignan, Michel, Federico, Massimo, André, Marc, LYSA-FIL-EORTC Intergroup
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(2), 327-335. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, no. 2, p. 327-335 (2022)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, no. 2, p. 327-335 (2022)
PURPOSE The prognosis of patients with early-stage unfavorable Hodgkin lymphoma remains unsatisfactory. We assessed the efficacy and safety of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (BV-AVD) in previously untreated, early-
Autor:
Josien C. A. Jenniskens, Kelly Offermans, Colinda C. J. M. Simons, Iryna Samarska, Gregorio E. Fazzi, Jaleesa R. M. van der Meer, Kim M. Smits, Leo J. Schouten, Matty P. Weijenberg, Heike I. Grabsch, Piet A. van den Brandt
Publikováno v:
Molecular Carcinogenesis, 61(12), 1099-1115. Wiley-Liss Inc.
KRAS mutations (KRASmut ), PIK3CAmut , BRAFmut , and deficient DNA mismatch repair (dMMR) have been associated with the Warburg effect. We previously reported differential associations between early-life energy balance-related factors (height, energy
Autor:
S, Baker, B, Mou, W, Jiang, M, Liu, A M, Bergman, D, Schellenberg, A S, Alexander, H, Carolan, S, Atrchian, T, Berrang, A, Bang, N, Chng, Q, Matthews, S, Tyldesley, R A, Olson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:849-855
The recently developed European Society for Radiotherapy and Oncology (ESTRO)/European Organization for Research and Treatment of Cancer (EORTC) oligometastatic disease (OMD) classification has not been validated in terms of its prognostic significan
Autor:
Charles Faselis, Joel A. Nations, Charity J. Morgan, Jared Antevil, Jeffrey M. Roseman, Sijian Zhang, Gregg C. Fonarow, Helen M. Sheriff, Gregory D. Trachiotis, Richard M. Allman, Prakash Deedwania, Qing Zeng-Trietler, Daniel D. Taub, Amiya A. Ahmed, George Howard, Ali Ahmed
Publikováno v:
JAMA Oncol
ImportanceThe US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more y
Autor:
Sarah Baker, Will Jiang, Benjamin Mou, Chad R. Lund, Mitchell Liu, Alanah M. Bergman, Devin Schellenberg, Abraham S. Alexander, Hannah Carolan, Siavash Atrchian, Nick Chng, Quinn Matthews, Gregory Arbour, Alexander Benny, Scott Tyldesley, Robert A. Olson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:617-626
Despite increasing utilization of SABR for oligometastatic cancer, prospective outcomes are lacking. The purpose of this study was to determine progression-free survival (PFS), local control (LC), and prognostic factors from the population-based phas
Autor:
Thi-Van-Trinh Tran, Carole Rubino, Rodrigue Allodji, Milena Andruccioli, Stéphane Bardet, Ibrahima Diallo, Massimo Dottorini, Jérome Garsi, Per Hall, Michel Henry-Amar, Stephanie Lamart, Françoise Le Thai, Stefan Lönn, Marcel Ricard, Claire Schvartz, Martin Schlumberger, Neige Journy, Florent de Vathaire
Publikováno v:
British Journal of Cancer. 127:2118-2124
Female thyroid cancer survivors are more likely to have a higher risk of breast cancer compared to the general population, and the underlying causes are yet to be understood. The potential role of I-131 treatment on this association remains controver
Autor:
Quinn T Ostrom, Mackenzie Price, Corey Neff, Gino Cioffi, Kristin A Waite, Carol Kruchko, Jill S Barnholtz-Sloan
Publikováno v:
Neuro-Oncology. 24:v1-v95
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and
Autor:
Surabhi Tewari, Martin C. Tom, Deborah Y.J. Park, Wei Wei, Samuel T. Chao, Jennifer S. Yu, John H. Suh, Sarah Kilic, David M. Peereboom, Glen H.J. Stevens, Justin D. Lathia, Richard Prayson, Gene H. Barnett, Lilyana Angelov, Alireza M. Mohammadi, Manmeet S. Ahluwalia, Erin S. Murphy
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:283-292
In addition to established prognostic factors in low-grade glioma (LGG), studies suggest a sexual dimorphism with male sex portending worse prognosis. Our objective was to identify the effect of sex on presentation and outcomes in LGG.We conducted a
Autor:
Kreepa G Kooblall, Victoria J Stokes, Omair A Shariq, Katherine A English, Mark Stevenson, John Broxholme, Benjamin Wright, Helen E Lockstone, David Buck, Simona Grozinsky-Glasberg, Christopher J Yates, Rajesh V Thakker, Kate E Lines
Publikováno v:
Endocrine-Related Cancer. 29:557-568
Multiple endocrine neoplasia type 1 (MEN1), caused by mutations in the MEN1 gene encoding menin, is an autosomal dominant disorder characterised by the combined occurrence of parathyroid, pituitary and pancreatic neuroendocrine tumours (NETs). Develo